48 results about "Chonemorpha" patented technology

The invention discloses a Chinese herbal medicine for treating gout, and the medicine is prepared by the following medicaments by weight: 20-30 parts of saposhnikovia divaricata; 20-30 parts of rhizoma et radix notopterygii; 25-35 parts of Ligusticum wallichii; 10-20 parts of rhizoma typhonii; 20-30 parts of heracleum; 20-40 parts of ventilago leiocarpa benth; 10-30 parts of Celastrus orbiculatus; 10-30 parts of Chonemorpha eriostylis; 6-12 parts of vernonia patula; and 10-30 parts of partia. The Chinese herbal medicine is prepared by the steps of: adding 1200 parts of water into the above medicaments and boiling them, then conducting decocting with mild fire for 20-30m and for 3 times, mixing the upper slag solutions from the 3 times of decoction uniformly, filtering the mixed solution which is then filled in bottles, and carrying out high temperature disinfection for standby use. In the formula of the invention, saposhnikovia divaricata are taken as the monarch medicine; rhizoma typhonii, heracleum, ventilago leiocarpa benth and Celastrus orbiculatus are adopted as the assistant medicines; Chonemorpha eriostylis, vernonia patula and partia are employed as the guide medicines. The Chinese herbal medicine provided in the invention has the advantages of simple preparation, technical operation easy to learn, low production cost, convenience for patient administration, safety, and no side effect, thus being an ideal medicine for treating gout.

The invention discloses a traditional Chinese medicine preparation for treating diabetes mellitus arteriosclerosis obliterans. According to the traditional Chinese medicine, main pathogenesis of the disease is blocked qi and blood, vessel insufficiency, meridian fatigue and resistance developed on the basis of pathogenesis of yin and fluid deficiency and dryness-heat excess of diabetes, so as to generate various concurrent symptoms. The internal traditional Chinese medicines such as lousewort root, rust-coloured crotalaria herb with root, fine-stemmed dendrobium, dunn antiotrema root, sago leaf, laxflower pottsia root and rubia yunnanensis are selected to be matched with the traditional Chinese medicines for soaking and washing, such as caesalpinia minax hance, pteracanthus root, luffa root, longcalyx chonemorpha stem, micromeria biflora benth and piper sarmentosum leaf for treatment. According to a clinical experiment, a relatively good curative effect is obtained; and the side effect is small.

The invention discloses a Chinese medicine external application agent for treating bone fractures and belongs to the technical field of traditional Chinese medicine. Setting about promoting peripheral hemangiectasis and promoting flow of qi and blood, traditional Chinese medicine materials of stems of chonemorpha megacalyx Pierre, conespike flemingia leaves, loofa roots, roots of womwoodleaf ampelocissus, berry-bearing campion herb, all-grass of tripterospermum, narrowleaf rockvine roots or herb, obovateleaf actinodaphne bark, all-grass of ceropegia christenseniana Hand.-Mazz., treasure maesa herb, purpleflower stonecrop herb, roots of oriental grape and herb of Japanese ophiorrhiza are selected and prepared into the external application agent, and clinical tests show that the total effective rate reaches 96.3%.

The invention belongs to the technical field of medicines and in particular relates to black ointment for treating rheumatic ostealgia and a production method thereof. The traditional Chinese medicinecomposition is prepared from the following raw materials in parts by weight: rhizoma paridis, radix aconiti kusnezoffii praeparata, radix aconiti preparata, radix aconiti penduli, rhizoma pinelliae,rhizoma arisaematis, rhizoma panacis japonici, radix angelicae pubescentis, monkshoodvine root-bark, herba peristrophes, rhizoma seu radix notopterygii, rhizoma curcumae, radix curcumae, dung beetle,radix achyranthis bidentatae, hairyleaf chonemorpha root or stem, cortex eucommiae, common sinopodophyllum root, eupolyphaga, pheretima, herba artemisiae rupestris preparata, rhizoma corydalis, radixclematidis, black sesame oil, tung oil, sangusis draconis, cortex daphnes, frankincense, borneol, myrrh and yellow lead. The black ointment for treating the rheumatic the ostealgia provided by the invention has the effects of promoting flow of Qi and activating blood circulation, promoting blood circulation and removing blood stasis, dispelling wind and eliminating dampness, removing blood stasisand removing pain or numbness, relieving swelling and pain, strengthening the body resistance and removing pathogenic factors, clearing and activating channels and collaterals, relieving distension and eliminating stagnation and strengthening tendons and bones; the black ointment is applicable to traumatic injuries, old wound recurrence, lumbar muscle degeneration, cervical and lumbar vertebrae disc herniation, osteoproliferation, sciatica, scapulohumeral periarthritis and rheumatic arthritis and the production method is simple and feasible.

The invention discloses a traditional Chinese medicinal composition for treating post-traumatic brain syndrome. Post-traumatic brain syndrome belongs to the field of stagnation of blood and headache in traditional Chinese medicine science. Head trauma often induces fear of patients, fear causing qi collapse, occlusion of upper jiao and functional activities of qi, and subsidence of lucid yang, further causing symptoms of headache, vertigo, listlessness, asthenia, mental uneasiness, palpitation and so on. Traditional Chinese medicinal materials with effects of relieving depression of the liver-qi, relieving the depressed liver, nourishing yin, supplementing qi, promoting blood circulation, dispelling blood stasis, regulating the flow of qi, calming the pathogenic wind, relieving mental uneasiness and inducing resuscitation, including Litsea cubeba stem, Akebia quinata, Cynanchum inamoenum, Orchis latifolia, Chonemorpha megacalyx stem, Cymbidium ensifolium root, Doellingeria scaber root, Abies chensiensis, Gynura bicolor and Spinacia oleracea seed, are decocted in water to obtain decoction. Through clinical trials, the total effective rate is up to 96.8%, which is obviously superior to the total effective rate (75.8%) of control group, and the therapeutic effect is distinct.

The invention belongs to the field of biopesticides and relates to a plant source herbicide. The plant source herbicide is prepared by uniformly mixing chonemorpha splendens methanol extract, a cosolvent, a surfactant, a preservative, a stabilizer and water, wherein the chonemorpha splendens methanol extract is obtained by washing collected chonemorpha splendens, drying the chonemorpha splendens in the shade and crushing, adding methanol to digest and extract at a shady place, and decompressing and concentrating an extracting solution into paste. According to the plant source herbicide, the process is simple, and the materials are convenient to obtain and the cost is low; the chonemorpha splendens methanol extract is used as an active component, thus weeds can be effectively killed; the plant source herbicide is easy to degrade in the environment and the residues of chemical agents in a field are reduced, so that the plant source herbicide is environmentally friendly and has practical significance.

The invention belongs to the technical field of medicines and in particular relates to a traditional Chinese medicine used for treating facioplegia. The traditional Chinese medicine used for treating the facioplegia is prepared from the following traditional Chinese medicine raw materials in parts by weight: 8-14 parts of aralia undulata, 8-14 parts of smallflower iris root and rhizome, 8-14 parts of mountain celery root, 5-13 parts of swida macrophylla, 4-8 parts of aristolochia impressinervis, 5-13 parts of chonemorpha megacalyx pierre, 8-14 parts of lysimachia barystachys bunge, 2-4 parts of human placenta, 8-14 parts of herba lycopi, 5-13 parts of cinnamomum wilsonii, 5-13 parts of giantleaf ardisia rhizome and 4-8 parts of liquorice. The traditional Chinese medicine used for treating the facioplegia is mainly based on a human body holism concept, focuses on causes and pathologies and has the advantages of speediness in healing, economy and no obvious toxic or side effect.

The ivnetnion discloses a meridian-activating pain-stopping radix notoginseng medicine, prepared of radix notoginseng, Santiaojin, Chonemorpha megacalyx Pier, Jiyi, Zanthoxylum planispinum Sieb.et Zucc, InterKadura Stem, Anemone flaccida Fr Schmidt, Yinxiangpi, Sargentgloryvine Stem, Clematis armandii Franch and alcohol in a certain weight proportion; these drugs cooperate to be able to effectively treat rheumatic muscles and bones pains, traumatic injury, traumatic gall, soft tissue injury, rheumatic arthritis, atrophic arthritis, etc; and it is a meridian-activating pain-stopping medicine having characters of low cost, reasonable formula, simple to prepare, completely convenient to use, fast curing, and good curative effect.

The present invention discloses a millettia root and stem medicine for external application for effectively curing the diseases of rheumatic arthralgia and myalgia, rheumatic bone pain, traumatic injuries and rheumatic arthritis, etc. It is made up by using millettia root and stem, formosan elder, vaccinium dunalianum, pedicularis rex, chonemorpha megacalyx, dragon's blood, goupima and ethyl alcohol through a certain preparation process.

The invention provides traditional Chinese medicine for treating stomach cancer with a syndrome of static blood in stomach collaterals and a preparation method thereof. The traditional Chinese medicine is prepared from all grass of highstalk razorsedge, capparis bodinieri, large-calyx chonemorpha eriostylis, Japanese banana flower, the root of prinos-like salacia, hastateleaf raspberry, pinellia integrifolia, stems and leaves of wild spikenard, synedrella nodiflora, Chinese tamarisk, night worms, bee medicine, the stem of common stelmatocrypton, the roots of rustyhair raspberry and millipede. The traditional Chinese medicine has the advantages of being high in pertinence for the stomach cancer with the syndrome of static blood in stomach collaterals, having no toxic or side effect, and being capable of significantly relieving the symptoms of a patient having the stomach cancer with the syndrome of static blood in stomach collaterals, improving living quality and prolonging survival time.

The present invention discloses Chinese medicine tongbangchui liquor for effectively curing the diseases of rheumatic arthritis, rheumatic arthralgia and myalgia, pain due to wind-dampness and traumatic injuries, etc. It is made up by using Chinese medicinal material tongbangchui, cyperus fuscus, chonemorpha megacalyx, panax pseudo-ginseng, phlegmariurus fargesii and white liquor through a certain preparation process.

The invention discloses a traditional Chinese medicine composition for treating scapulohumeral periarthritis. The composition is prepared from the following traditional Chinese medicinal raw materials in parts by weight: 10-30 parts of kudzu vine roots, 10-20 parts of Chinese dates, 10-20 parts of cornus officinalis, 5-15 parts of incised notopterygium, 10-20 parts of dendrobe, 10-20 parts of honeysuckle stems, 10-20 parts of rhizoma arisaematis, 5-15 parts of herba aristolochiae, 10-20 parts of verbena officinalis, 10-20 parts of herba pyrolae, 10-20 parts of obscured homalomena rhizome, 5-15 parts of erycibe obtusifolia benth, 10-20 parts of radix plumbaginis zeylanicae, 10-20 parts of geranium wilfordii, 5-15 parts of ligusticum wallichii, 10-20 parts of polygonum cuspidatum, 10-20 parts of chonemorpha megacalyx, 5-15 parts of cassia twigs, 10-20 parts of pterygopleurum neurophyllum, 10-20 parts of turtle shell, 5-15 parts of pachysandra terminalis, 10-20 parts of herba epimedii, 10-20 parts of serissa japonica and 5-15 parts of licorice root. The traditional Chinese medicine composition has the effects of tonifying liver and kidneys, tonifying middle-warmer and qi, relaxing muscles and tendons, removing obstructionfrom meridians, expelling wind and removing cold, and has a remarkable curative effect and reliable effect when being used for treating scapulohumeral periarthritis.

The invention discloses a traditional Chinese medicine preparation for treating the yin-cold stagnation type coronary heart disease. According to the pathogenesis, traditional Chinese medicines, namely, mongollian thyme herb, Japanese galangal rhizome, Chinese leek roots, herb of gold stargrass, cinnamomum bodinieri, luffa roots, chonemorpha megacalyx pierre, parthenocissus roots and stems, Chinese carlesia, lilyofthevalley herb, goat-ear elecampane roots and arachnoid cyanotis roots which have functions of freeing yang with warmth and acridity, dispersing blood stasis, dredging collaterals, diffusing impediment and dispelling cold are selected and decocted with water into a decoction, and clinical contrast tests indicate that the curative effect of the treatment group is obviously superior to that of the control group, and the preparation is small in side effect and worthy of clinical promotion and application.

The invention discloses a traditional Chinese medicine preparation for treating peripheral facial paralysis. The traditional Chinese medicine considers that the wry mouth is caused by the fact that wind pathogens enter midface meridians and collaterals due to insufficient anti-pathogenic energy, weakness of meridian and collaterals, and defensive qi instability, or inherent wind phlegm and blood stasis in a body and blocking of facial meridians and collaterals. Therefore, traditional Chinese medicines including smilax riparia, roots of gynura bicolor, cyperus difformis, herb of selaginella davidii, roots of berchemia floribunda, sopubia trifida, aralia elata, crotalaria ferruginea, herb of tree clubmoss, chonemorpha megacalyx and mucuna sempervirens are decocted into decoction with water. A clinical test result shows that the total effective rate is 92.73% and is obviously superior to 73.33% of a control group, and curative effect is obvious.

The present invention discloses a Tetrastigma delavayi Huoluo Shangshi Zhitong adhesive plaster. It has the functions of expelling wind, removing dampness, relaxing muscles and tendons to promote circulation of qi, promoting circulation and stopping pain and can be used for effectively curing the diseases of traumatic injury, rheumatic numbness, rheumatic arthritis, rheumatoid arthritis soft tissue injury, etc. with obvious therapeutic effect. It is made up by using 9 Chinese medicinal materials of tetrastigma delavayi, munronia sinica, chonemorpha megacalyx, cirsium japonicum, clematis chrysocoma and others through a certain preparation process. Said invention also provides the concrete steps of its preparation process.

The invention provides traditional Chinese medicine for treating injury stasis type femoral head necrosis and a preparing method. The raw material medicine materials of the traditional Chinese medicine comprise tiarella polyphylla, prinsepia utilis, anderson ironweed stems, glossogyne tenuifolia, hairy fig, Schisandra lancifolia, incurved columbine, Girardinia chingiana Chien, sinense knotweed rhizome, sinomenium acutum, falcate dolichos root leaves, nipponian greenbrier rhizome and roots, Chonemorpha megacalyx Pierre, Ichnocarpus frutescens, whorled litsea, radix caulophylli and Thunbergia grandiflora. The traditional Chinese medicine has a definite curative effect on injury stasis type femoral head necrosis, and toxic and side effects are low.

The invention discloses a medicinal composition for treating periodontitis, and a preparation method thereof. The medicinal composition is formed by proportioning raw materials of cormorant bone, chonemorpha valvata chatt, mulberrofuran C, lysimachia hemsleyana and gampsocleis buerger; the medicinal composition is prepared into various preparations according to conventional preparation processes; and the treatment effect of treating the periodontitis is remarkable.

The invention discloses a Chinese medicinal composition for treating cold-damp coagulation type sciatica. The Chinese medicinal composition is characterized by being prepared from the following drugs by weight: 25-30 parts of Humata tyermanni Moore, 12-15 parts of cochinchina raspberry root or leaf, 40-50 parts of root or branch of Ficus simplicissima, 30-40 parts of Pterospermum heterophyllum hance, 20-25 parts of tetrastigma planicaule, 12-15 parts of Chonemorpha megacalyx Pierre, 5-10 parts of Litsea verticillata Hance, 20-25 parts of Artocarpus styracifolius Pierre, 40-50 parts of Euonymus nitidus, 15-20 parts of root of Uvaria microcarpa, 9-12 parts of Aralia cordata, 6-9 parts of Pimpinella coriacea, 3-6 parts of Polyporus elegans, 12-15 parts of Pubescent Pepper Herb, 6-9 parts of root or leaf of Narrowleaf Burmann cinnamon, 6-9 parts of Burmann Cinnamon Bark, and 3-6 parts of licorice. The Chinese medicinal composition provided by the invention is used for treating cold-damp coagulation type sciatica, and has the advantages of high effective rate, reliable curative effect, after healing, and no recurrence after cure.

The invention discloses a traditional Chinese medicine tincture for treating tinea manus and tinea pedis. Traditional Chinese medicine holds that the tinea manus and tinea pedis is mostly caused by internal damp-heat stagnation and external pathogenic toxin invasion, body fluid and blood are consumed if patients suffer tinea manus and tinea pedis for a long time, and skin is not nourished, so that skin is thick, dried and cracked. The traditional Chinese medicine tincture is prepared from the following traditional Chinese medicinal materials with effects of clearing heat, drying dampness, killing parasites to relieve itching, promoting blood circulation to nourishing dryness: small-leaved desmodium, drymoglossum piloselloides presl, caudate sweetleaf root, chonemorpha megacalyx pierre, feather cockscomb, chenopodium iljinii, alate senna leaf, axillary choerospondias bark, concha arcae, longspurred fairybells rhizome and flabellate hemipilia herb. The traditional Chinese medicine tincture is applied to an affected position. Clinical tests prove that the total effective rate is 97.5 percent, and the curative effect is remarkable.

The invention provides a tissue culture and rapid propagation method of cynanchum glaucescens. According to the tissue culture and rapid propagation method, spores of the cynanchum glaucescens are used as materials, tests and comparison are carried out in the aspects of spore germination, sporophyte induction, sporophyte root proliferation, rooting seedling treatment with allogenic materials to improve the adaptability of the sporophyte, a tissue culture and rapid propagation system of the neospora virens is established, the tissue culture process is optimized, the survival rate of transplanted and hardened seedlings is increased, and the mass breeding of the tissue culture seedlings of the cynanchum glaucescens is realized. According to the method, technical support is provided for industrial development and utilization of the cynanchum glaucescens, meanwhile, a guarantee is provided for population recovery and wild resource protection of the cynanchum glaucescens, the method is also suitable for tissue culture and rapid propagation of the chonemorpha bifida.